Top Stories
The startup's V-Link platform recently nabbed an FDA breakthrough device designation for reducing cerebral vasospasm in adults with aneurysmal subarachnoid haemorrhage.
Chief scientific officer Robert Abel told FirstWord that one of the challenges of early drug discovery is choosing which ideas and hypotheses "deserve the time and resources to become experiments."
Abbott will commercialise SimpleScreen exclusively in the US, with the approval triggering a $100-million milestone payment to Freenome.
The PCR assay is designed to distinguish between bacterial vaginosis and Candida vaginitis, conditions with overlapping symptoms that can be misdiagnosed.
The Cambridge startup's handheld device analyses carbon dioxide during relaxed breathing, offering clinics a faster alternative to specialist-run spirometry.
Conference News
Results discussed today at the ADLM 2026 meetingANAHEIM, Calif., July 28, 2026 /PRNewswire/ -- A new study presented today at ADLM 2026 in Anaheim, California found that a simple blood test could accu...
Tarrytown, NY (USA), July 28, 2026 (GLOBE NEWSWIRE) --C-suites are investing in enhanced lab services, prioritizing lab upgrades just behind AI82% of healthcare executives surveyed considered expandin...
HOUSTON, July 28, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing targeted therapeutics and diagnostics for central...
28-Jul-2026 at 12:30 PM EDT, by Association for Diagnostic and Laboratory Medicine (ADLM)Newswise — ANAHEIM, Calif. – A team of researchers for the first time has established comprehensive, age-specif...
Results discussed today at the ADLM 2026 meeting28-Jul-2026 at 12:30 PM EDT, by Association for Diagnostic and Laboratory Medicine (ADLM)Newswise — ANAHEIM, CALIF. — A new study presented today at ADL...
